期刊文献+

热休克蛋白70在兔非酒精性脂肪肝纤维化过程中的作用 被引量:4

Effect of HSP70 on Fibrosis of Nonalcoholic Fatty Liver Disease in Rabbits
下载PDF
导出
摘要 目的 探讨热休克蛋白70(HPS70)在兔非酒精性脂肪肝(NAFLD)纤维化形成过程中的作用.方法 40只雄性日本大耳兔随机分为正常对照组和NAFLD模型组,其中对照组取8周为时相点,模型组取4周、6周、8周3个时相点,每个时相点各10只.模型组分别皮下注射花生油4周、6周、8周,2次/周,每次1.2 ml/kg,建立日本大耳兔NAFLD模型.按时间点处死各组动物,测定兔血清中ALT、AST、TC、TG、FFA、空腹血糖(FBG)、HSP47、HSP70、HA、PC Ⅲ、C Ⅳ、LN的含量和空腹胰岛素(FINS)的水平,并计算胰岛素抵抗指数(HOMA-IR); MASSON染色观察肝组织病理形态改变;免疫组化观察HSP47和HSP70的表达情况.结果 与对照组相比,模型组肝功能、脂质代谢和肝纤维化相关指标水平升高,造模4周时出现肝功能损伤,脂质代谢紊乱、胰岛素抵抗,随着NAFLD肝纤维化进程的发展,HSP70表达量逐渐增加.结论 HSP70的表达与NAFLD肝纤维化程度呈正相关,可能与NAFLD肝纤维化发生发展密切相关. Objective To investigate the change of HSP70 in nonalcoholic fatty (NAFLD) liver fibrosis of rabbit. Methods Forty male Japanese white rabbits were randomly assigned to control group and model group. The model group was divided into three subgroups, as 4-week, 6-week, 8-week groups, with 10 rabbits in each, and treated with peanut oil (1.2 ml/kg) subcutaneously (s.c.), twice a week for 4 weeks, 6 weeks and 8 weeks respectively. The rabbits of all groups were sacrificed at the designed time point. Samples of serum were collected for detecting the serum ALT, AST, TC, TG, FFA, FBG, HSP47, HSP70, HA, PC?, C/∞, LN ,and the HOMA-IR were calculated. The liver tissues were collected for histopathological and immunohistochemical observation. Results The model groups had hepatic injury and high level of insulin at the beginning of 4 weeks. With the process of NAFLD liver fibrosis, HSP70 had gradually increased. Conclusion The expression of HSP70 was positively corre- lated with NAFLD liver fibrosis, and it might have close relation with the development of NAFLD liver fibrosis.
出处 《实验动物与比较医学》 CAS 2014年第2期107-112,共6页 Laboratory Animal and Comparative Medicine
关键词 非酒精性脂肪肝 肝纤维化 热休克蛋白70 胰岛素抵抗 NAFLD Liver fibrosis HSP70 HOMA-IR
  • 相关文献

参考文献9

二级参考文献72

  • 1王宝恩,王志富.实验性免疫性肝纤维化模型的研究[J].中华医学杂志,1989,69(9):503-505. 被引量:145
  • 2郭兴中.热耐受机制[J].生命的化学,1996,16(2):12-13. 被引量:4
  • 3任莉萍,曹小汉.热休克蛋白研究进展[J].安徽农业科学,2006,34(10):2040-2042. 被引量:10
  • 4钟民涛,黄敏,卢静,孟霞,王钜.长爪沙鼠速发型高脂血症模型的初步建立[J].中国实验动物学报,2006,14(3):217-221. 被引量:27
  • 5顾小红,房殿春,陈东风.胆管结扎大鼠肝纤维化模型中HSC的分离和培养及PAR_S的表达[J].胃肠病学和肝病学杂志,2006,15(5):474-477. 被引量:8
  • 6Chen J,Schaefer R,Mehta JL.Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in Apo-E knockout mice:Novel insights into the role of RAS and dyslipidemia in atherogenesis[J].J Cardiovasc Pharmacol,2004,44(4):446-452.
  • 7Tsimikas S,Witztum JL,Miller ER,et al.High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial[J].Circulation,2004,110(11):1406-1412.
  • 8Horkko S,Miller E,Branch DW,et al.The epitopes for some antiphospholipid antibodies are adducts of oxidized phos-pholipid and beta2 glycoprotein 1 (and other proteins)[J].Proc Natl Acad Sci USA,1997,94(19):10356-10361.
  • 9Hulthe J.Antibodies to oxidized LDL in atherosclerosisdevelopment(木含)linical and animal studies[J].Clin Chim Acta,2004,348(1-2):1-8.
  • 10Kayo S,Ohsawa M,Ehara S,et al.Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues:comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction[J].Am Heart J,2004,148(5):818-825.

共引文献366

同被引文献27

  • 1朱学海,赖志刚,魏代奎.磷酸吡哆醛在丙氨酸转氨酶测定中的应用[J].检验医学,2005,20(4):386-388. 被引量:3
  • 2齐志宏,郑可,宋耀虹.常规试剂加入磷酸吡哆醛测定丙氨酸转氨酶催化活性浓度的研究[J].北京医学,2007,29(2):95-97. 被引量:5
  • 3齐志宏,郑可,宋耀虹.常规试剂中加入磷酸吡哆醛(PPA)测定天门冬氨酸氨基转移酶(AST)催化活性浓度的可行性研究[J].中国实验诊断学,2007,11(5):630-633. 被引量:2
  • 4The National Committee for Clinical Laboratory Standards.EP9-A2: Method Comparison and Bias Estimation UsingPatient Samples; Approved Guideline-Second Edition[S].Wayne, PA, USA: NCCLS,2002.
  • 5Farrell GC, Wong VWS, Chitturi S. NAFLD in Asia--as common and important as in the West [ J ]. Nature Rev Gastroenterol Hepatol, 2013, 10(5) : 307.
  • 6Day CP. Non-alcoholic fatty liver disease: a massive problem [J]. Clin Med, 2011,11(2):176-178.
  • 7Daugherity EK, Balmus G, Saei AA, et al. The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease [ J]. Cell Cycle, 2012, 11(10) : 1918 -1928.
  • 8Cheng Q, Li N, Chen MQ, et al. Cyclooxygenase-2 promotes hepatoeellular apoptosis by interacting with TNF-ct and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats [J]. Digest Dis Sci, 2013, 58(10) : 2895 -2902.
  • 9Kathirvel E, Morgan K, French SW, et al. Aeetyl-l-earnitiue and lipoic acid improve mitochondfial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease [J]. Nutrit Res, 2013, 33(11): 932-941.
  • 10Garcfa RC, Baulies A, Mari M, et al. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence? [J]. Free Radical Res, 2013, 47 (11): 854 -868.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部